BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 16421230)

  • 1. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral signaling through pattern recognition receptors.
    Kawai T; Akira S
    J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S; Miyake K
    Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial nucleic acids pay a Toll in kidney disease.
    Pawar RD; Patole PS; Wörnle M; Anders HJ
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F509-16. PubMed ID: 16597607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFNs activate toll-like receptor gene expression in viral infections.
    Miettinen M; Sareneva T; Julkunen I; Matikainen S
    Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
    Ashkar AA; Yao XD; Gill N; Sajic D; Patrick AJ; Rosenthal KL
    J Infect Dis; 2004 Nov; 190(10):1841-9. PubMed ID: 15499542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells.
    Ebihara N; Chen L; Tokura T; Ushio H; Iwatsu M; Murakami A
    Ophthalmic Res; 2007; 39(3):155-63. PubMed ID: 17534115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
    Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
    J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
    Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
    Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sweetness of the DNA backbone drives Toll-like receptor 9.
    Wagner H
    Curr Opin Immunol; 2008 Aug; 20(4):396-400. PubMed ID: 18656540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
    Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R
    J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S; Kandimalla ER
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.